Introduction
Background
Large language models (LLMs) represent a breakthrough in artificial intelligence (AI), capable of processing, understanding, and generating humanlike language at scale. With their advanced natural language processing…

Large language models (LLMs) represent a breakthrough in artificial intelligence (AI), capable of processing, understanding, and generating humanlike language at scale. With their advanced natural language processing…

The PD-L1–directed antibody-drug conjugate (ADC) HLX43 has received orphan drug designation from the FDA for the treatment of patients with thymic epithelial tumors.1
At a data cutoff of June 28, 2025, findings from a phase 1 study…

This content was independently produced by Pharmacy Times in partnership with Bayer Healthcare.
When treating women across different populations, 120 mg of elinzanetant (Bayer Healthcare) reduced the frequency and severity of moderate-to-severe…

Long-term findings from the phase 3 DeFi trial (NCT03785964) demonstrated sustained efficacy and a consistent safety profile with nirogacestat (Ogsiveo), an oral γ-secretase inhibitor, for the treatment of adult patients with progressing…

The company has developed a no-code platform that leverages generative AI to teach websites to evolve independently to increase conversions, sales, and revenue.

The State Comptroller found that over 900,000 apartments – about half of the homes listed in the Land Registry – do not appear in the Israel Tax Authority’s real estate database.

IUCN played a leading role throughout the week, demonstrating the power of the GBW Initiative in advancing science, policy, and community-led action across the Western Indian Ocean. The team’s engagement spanned five days, over 15 co-led…

The FDA has granted fast track designation to the selective HDAC8 inhibitor NBM-BMX for use as a therapeutic option in patients with metastatic uveal melanoma, according to an announcement from NovelWise Pharmaceutical Corporation.1
The agent is…